DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Iglicki, Matias; Busch, Catharina; Zur, Dinah; Okada, Mali; Mariussi, Miriana; Chhablani, Jay; Cebeci, ZAFER; Fraser-Bell, Samantha; Chaikitmongkol, Voraporn; Couturier, Aude; Giancipoli, Ermete; Lupidi, Marco; Rodriguez-Valdes, Patricio; Rehak, Matus; Fung, Adrian; Goldstein, Michaella; Loewenstein, Anat

doi:10.1097/iae.0000000000002196

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Iglicki M., Busch C., Zur D., Okada M., Mariussi M., Chhablani J. K., ...Daha Fazla

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, cilt.39, sa.1, ss.44-51, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 1
Basım Tarihi: 2019
Doi Numarası: 10.1097/iae.0000000000002196
Dergi Adı: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.44-51
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.